Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 2/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27887981 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL5524091 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL28401374 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL336491 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL9981037 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL25328762 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL30203014 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL30933015 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL336374 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA | |
| SCHEMBL26922251 | 1.00 | PAM (0.51) | PAMGPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018155974-A1 | COSMETIC COMPOSITION FOR FILTERING BLUE LIGHT AND BLOCKING ULTRAVIOLET RAY | (주)아모레퍼시픽 | 2018-08-30 | — | — | WO | disclosed |
| EP-0981328-B1 | COMPOSITION FORMING AN EMULSION FOR A TAXOID COMPOUND | SONUS PHARMA INC (US) | 2007-03-14 | — | — | EP | disclosed |
| US-7030155-B2 | Emulsion vehicle for poorly soluble drugs | SONUS PHARMACEUTICALS, INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-6982282-B2 | Emulsion vehicle for poorly soluble drugs | SONUS PHARMACEUTICALS, INC. (US) | 2006-01-03 | — | — | US | disclosed |
| US-20050142189-A1 | Emulsion vehicle for poorly soluble drugs | SONUS PHARMACEUTICALS, INC. | 2005-06-30 | — | — | US | disclosed |
| US-20040202712-A1 | Emulsion vehicle for poorly soluble drugs | SONUS PHARMACEUTICALS, INC. | 2004-10-14 | — | — | US | disclosed |
| US-20040053993-A1 | Compositions of tocol-soluble therapeutics | SONUS PHARMACEUTICALS, INC. | 2004-03-18 | — | — | US | disclosed |
| US-6667048-B1 | Pharmaceutical composition comprising taxoid, taxane or taxine as chemotherapeutic agent, alpha-tocopherol, tocopherol polyethylene glycol succinate, and aqueous phase, in form of emulsion or microemulsion with drug in oil phase | SONUS PHARMACEUTICALS, INC. | 2003-12-23 | — | — | US | disclosed |
| US-6660286-B1 | Tocopherol as primary solvent and tocopherol polyethylene glycol succinate as secondary solvent; Vitamin E | SONUS PHARMACEUTICALS, INC. | 2003-12-09 | — | — | US | disclosed |
| US-20030170279-A1 | Emulsion vehicle for poorly soluble drugs | SONUS PHARMACEUTICALS, INC. | 2003-09-11 | — | — | US | disclosed |
| US-6479540-B1 | Compositions of tocol-soluble therapeutics | SONUS PHARMACEUTICALS, INC. | 2002-11-12 | — | — | US | disclosed |
| US-6458373-B1 | Emulsion vehicle for poorly soluble drugs | SONUS PHARMACEUTICALS, INC. | 2002-10-01 | — | — | US | disclosed |
| EP-1216026-A1 | COMPOSITIONS OF TOCOL-SOLUBLE THERAPEUTICS | SONUS PHARMACEUTICALS, INC. (US) | 2002-06-26 | — | — | EP | disclosed |
| WO-2002026208-A2 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 2002-04-04 | — | — | WO | disclosed |
| EP-1185301-A1 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 2002-03-13 | — | — | EP | disclosed |
| WO-2001022937-A1 | COMPOSITIONS OF TOCOL-SOLUBLE THERAPEUTICS | SONUS PHARMACEUTICALS, INC. (US) | 2001-04-05 | — | — | WO | disclosed |
| WO-2000071163-A1 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 2000-11-30 | — | — | WO | disclosed |
| EP-0981328-A1 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998030205-A9 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | — | 1998-12-30 | — | — | WO | disclosed |
| WO-1998030205-A1 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050142189-A1 | Emulsion vehicle for poorly soluble drugs | TTPA, SUCNR1, SDHA | PAM 2864/4885GPR84 695/4885PPARG 76/4885 |
| US-20030170279-A1 | Emulsion vehicle for poorly soluble drugs | TTPA, SUCNR1, SDHA | PAM 2969/4885GPR84 757/4885PPARG 59/4885 |
| US-20040053993-A1 | Compositions of tocol-soluble therapeutics | TTPA, SLC25A13, PCTP | PAM 2586/4885GPR84 872/4885PPARG 380/4885 |
| US-20040202712-A1 | Emulsion vehicle for poorly soluble drugs | TTPA, SUCNR1, SELE | PAM 2931/4885GPR84 709/4885PPARG 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.